These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2382671)

  • 21. QT bumps: unraveling the mechanisms.
    Roden DM
    J Cardiovasc Electrophysiol; 2001 Dec; 12(12):1379-80. PubMed ID: 11797995
    [No Abstract]   [Full Text] [Related]  

  • 22. Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers.
    Kaseda S; Gilmour RF; Zipes DP
    Am Heart J; 1989 Sep; 118(3):458-66. PubMed ID: 2549775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mexiletine: long-term follow-up of a patient with prolonged QT interval and quinidine-induced torsades de pointes.
    Thomas MG; Giles TD
    South Med J; 1985 Feb; 78(2):205-6. PubMed ID: 3919448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The action potential of the Purkinje fiber: an in vitro model for evaluation of the proarrhythmic potential of cardiac and noncardiac drugs.
    Picard S; Goineau S; Rouet R
    Curr Protoc Pharmacol; 2006 Jul; Chapter 11():Unit11.3. PubMed ID: 22294170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic modulation of ventricular arrhythmia in cesium chloride-induced long QT syndrome.
    Hanich RF; Levine JH; Spear JF; Moore EN
    Circulation; 1988 May; 77(5):1149-61. PubMed ID: 3359592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphous ventricular tachycardia due to alpha-blockade.
    James MA; Culling W; Vann Jones J
    Int J Cardiol; 1987 Feb; 14(2):225-7. PubMed ID: 3818139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of quinidine syncope by cardiac pacing].
    Gussarasky J; Kristal N; Gueron M
    Harefuah; 1972 Apr; 82(8):354-6. PubMed ID: 5050684
    [No Abstract]   [Full Text] [Related]  

  • 29. Realistic cardiac electrophysiology modelling: are we just a heartbeat away?
    Cherry EM; Fenton FH
    J Physiol; 2010 Aug; 588(Pt 15):2689. PubMed ID: 20675816
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
    Ophoff N; Toker Y
    Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced arrhythmia.
    Heist EK; Ruskin JN
    Circulation; 2010 Oct; 122(14):1426-35. PubMed ID: 20921449
    [No Abstract]   [Full Text] [Related]  

  • 32. Overdrive pacing in quinidine syncope and other long QT-interval syndromes.
    DiSegni E; Klein HO; David D; Libhaber C; Kaplinsky E
    Arch Intern Med; 1980 Aug; 140(8):1036-40. PubMed ID: 7396607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right ventricular monophasic action potentials in patients with long QT syndrome.
    Gavrilescu S; Luca C
    Br Heart J; 1978 Sep; 40(9):1014-8. PubMed ID: 708526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular arrhythmias and QT-prolongation during therapy with ketanserin: report of a case.
    Vandermotten M; Verhaeghe R; De Geest H
    Acta Cardiol; 1989; 44(5):431-7. PubMed ID: 2603605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2007 Dec; 577(1-3):222-32. PubMed ID: 18074444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Torsade de pointes.
    Roden DM
    Clin Cardiol; 1993 Sep; 16(9):683-6. PubMed ID: 7902224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electrophysiological study of pro-arrhythmogenic effects of erythromycin].
    Ponsonnaille J; Citron B; Richard A; Trolese JF; Chaperon A; Barret B; Gras H
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1001-8. PubMed ID: 3144248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
    Buxton AE; Josephson ME
    Circulation; 1986 Feb; 73(2 Pt 2):II67-72. PubMed ID: 3943175
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.
    Lu HR; Gallacher DJ; Yan GX
    J Pharmacol Toxicol Methods; 2016; 81():151-60. PubMed ID: 27374776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.
    Brachmann J; Scherlag BJ; Rosenshtraukh LV; Lazzara R
    Circulation; 1983 Oct; 68(4):846-56. PubMed ID: 6616779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.